2 septembre 2022 – The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended authorising two adapted versions of COVID-19 vaccines Comirnaty and Spikevax in vaccinated people aged 12 and over.

For more information, see here.